Your browser doesn't support javascript.
loading
A high-throughput bioanalytical assay to support pharmacokinetic interaction study of oxycodone and diazepam in Sprague Dawley rats.
Pilli, Nageswara R; Narayanasamy, Suresh; Xu, Lin; Chockalingam, Ashok; Shea, Katherine I; Stewart, Sharron; Rouse, Rodney; Patel, Vikram; Matta, Murali K.
Afiliação
  • Pilli NR; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring MD 20993 USA murali.matta@fda.hhs.gov +1-240-402-5325.
  • Narayanasamy S; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring MD 20993 USA murali.matta@fda.hhs.gov +1-240-402-5325.
  • Xu L; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring MD 20993 USA murali.matta@fda.hhs.gov +1-240-402-5325.
  • Chockalingam A; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring MD 20993 USA murali.matta@fda.hhs.gov +1-240-402-5325.
  • Shea KI; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring MD 20993 USA murali.matta@fda.hhs.gov +1-240-402-5325.
  • Stewart S; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring MD 20993 USA murali.matta@fda.hhs.gov +1-240-402-5325.
  • Rouse R; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring MD 20993 USA murali.matta@fda.hhs.gov +1-240-402-5325.
  • Patel V; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring MD 20993 USA murali.matta@fda.hhs.gov +1-240-402-5325.
  • Matta MK; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring MD 20993 USA murali.matta@fda.hhs.gov +1-240-402-5325.
RSC Adv ; 10(2): 886-896, 2020 Jan 02.
Article em En | MEDLINE | ID: mdl-35494453
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: RSC Adv Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: RSC Adv Ano de publicação: 2020 Tipo de documento: Article